Early Versus Late Use of Hi-VNI in Covid-19 | Clinical Trial | StuddyBuddy@endsection Early Versus Late Use of Hi-VNI in Covid-19
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05663138

Early Versus Late Use of Hi-VNI in Covid-19

Conditions: COVID-19

Sex: All
Ages: 18 Years – N/A
Enrollment: 30
Sponsor: Assiut University

Location: Egypt

Summary

This study evaluate early administration of high-velocity nasal insufflation in COVID-19 patients presented with acute respiratory failure after failure of conventional low flow nasal cannula bypassing the escalating step of Non re-breathing mask where early use of High velocity nasal insufflations achieved better improvement of respiratory distress, lower oxygen requirements and shorter ICU stay.

Eligibility Criteria

Inclusion Criteria:1-severe COVID Patients with hypoxemic respiratory failure. 2- Patients with no comorbiditiesExclusion Criteria:Non severe COVID PatientsPatients with comorbidities (e.g chronic chest dis, DM, renal failure and hepatic failurePatients indicated for mechanical ventilationPatients with marked hypercapnia in need for non-invasive ventilation

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05663138). StuddyBuddy aggregates publicly available trial information.